Skip to content

Daniel D. Long, SVP, Drug Discovery at Septerna, sold SEPN on Jul 1, 2026

Data as of Oct 27

▼ SELL$71.6K2,100 shares at $34.10Daniel D. Long SVP, Drug DiscoverySEPN Septerna, Inc.
Watch SEPN
Traded
Jul 1, 2026
Disclosed
Jul 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Daniel D. Long, SVP, Drug Discovery at Septerna, sold SEPN on Jul 1, 2026TRADEDDISCLOSED
SEPNSimilar stocks (XLV — its sector index fund), rebased to SEPN's price on the disclosure day
SEPN since disclosure
+29.8%
after the sale
Similar stocks (XLV) since disclosure
+9.4%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLDaniel D. Long SVP, Drug DiscoverySEPN Septerna, Inc.$42.9Kdisclosed Jul 2 · filed 1 day after the trade

See every trade on SEPN →